Camlin Fine Sciences Q2 FY27: Rev ₹5,199 Cr

Metric	Value
Revenue	₹5,199 Cr

🔮 What's Next
EBITDA margin target of 10-12% for FY27; double-digit EBITDA margins expected by Q3 2026; vanillin volume guidance revised to 3,000-4,000 tons for FY27; capacity expansion to 5,000 tons by FY28; INR100-150 crores funding round planned for working capital closure in 1-1.5 months; EBITDA target of INR220-230 crores for FY27.

💡 Investor Takeaway
Shareholders should note that while top-line growth is strong, margin recovery depends on vanillin utilization and raw material cost pass-through, with EBITDA targets requiring operational execution and capital raising.

Camlin Fine Sciences reported Q1 FY27 revenue of [amount not verified], up 28% YoY, driven by Specialty Ingredients (₹400 crores) and Performance Chemicals ([amount not verified]). EBITDA margin stood at 6.35%, under pressure from raw material and freight costs, though management targets 10-12% EBITDA margins by FY27 end. Capacity utilization for ethyl vanillin reached 95% customer approval, with sales of 350 metric tons and planned output of 500-600 tons next quarter. The diphenol plant remains shut, with liquidation costs estimated at 10-20 million. Insurance settlements totaled ₹400 crores, aiding financial recovery. Working capital pressures persist, with potential INR100-200 crores in market credit lines needed. EBITDA guidance for FY27 is INR220-230 crores, targeting double-digit margins by Q3 2026 as utilization improves and pricing stabilizes.

📄 View Original Announcement (PDF)

📊 Stock Analysis — CAMLINFINE ✨ Ask AI About This

About Camlin Fine Sciences Limited (CAMLINFINE)

Chemicals · Chemicals · Listed on NSE

Market Cap: ₹1,975.71 Cr ROE: 0.1% ROCE: 0.5%

View full CAMLINFINE stock details →

📡 Get AI alerts when CAMLINFINE files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track CAMLINFINE — Free

💡 Ask AI about this filing

"What is the timeline for achieving 10-12% EBITDA margins and how will it be sustained?" "How will the INR100-150 crore funding round be executed and what dilution risks exist?" "What specific cost pass-through mechanisms are in place for vanillin pricing in blends?"

Ask AI Free →

📊 More CAMLINFINE filings

See all CAMLINFINE filings →

🔥 Also filed on 17 August 2026

PREMIERENE Premier Energies Limited Announcement ABCAPITAL Aditya Birla Capital Limited Corporate Action VIVIMEDLAB Vivimed Labs Limited Announcement GSPCROP GSP Crop Science Limited Financial Results SEDEMAC SEDEMAC Mechatronics Limited Annual Report AFFLE Affle 3i Limited Financial Results

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when CAMLINFINE files new disclosures

Track CAMLINFINE filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track CAMLINFINE — Free

Free account · 2 AI queries/day

About · Privacy Policy · Terms of Service · Pricing

Today's Announcements · Screener · Insights · AI Chat

Data provided by CMOTS Internet Technologies Pvt Ltd